HCV Symposium 2011

2011 年丙型肝炎研讨会

• 批准号: 8128005
• 负责人: STEPHEN J. POLYAK
• 金额: $ 2.3万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8128005
• 关键词: Acute Hepatitis C; Africa; Antiviral Therapy; Asia; Awareness; Chronic; Chronic Hepatitis C; Cirrhosis; Country; Development; Disease; Education; Ensure; Epidemic; Europe; Fostering; Funding; Future; Genetic; Goals; Hepatitis; Hepatitis C; Hepatitis C virus; Immune response; Immunology; India; Infection; Interferons; International; Latin America; Lead; Life; Liver diseases; Malignant neoplasm of liver; Molecular Virology; Pathogenesis; Patients; Pharmaceutical Preparations; Prevention; Research; Research Personnel; Ribavirin; Risk; Scholarship; Scientist; Societies; Travel; United States National Institutes of Health; Virus; Virus Diseases; ethnic minority population; improved; interest; meetings; novel strategies; symposium; virology

DESCRIPTION (provided by applicant): Hepatitis C Virus (HCV) infects over 150 million people throughout the world and is a leading cause of liver disease (1). After discovery of the virus in 1989, the International Symposium on Hepatitis C Virus and Related Viruses (hereafter referred to as HCV Symposium) was founded in 1992 with the goals of increasing the scientific understanding of the virus, the disease, and to develop novel approaches for controlling its spread. The HCV Symposium is the leading international meeting for scientists and clinicians interested in the molecular virology, pathogenesis, prevention and treatment of chronic hepatitis C. In September 2011, over 800 researchers from around the world will congregate in Seattle, WA, to attend the 18th HCV Symposium. One long-term goal of the Symposium is to ensure the future of the meeting by expanding international awareness of the Symposium, and to attract scientists from countries that historically have not attended the Symposium. As part of these efforts, the Seattle organizing committee is obtaining endorsements from liver disease research societies in the USA, Europe, India, Latin America, Asia, and Africa. Therefore, this R13 application seeks NIH support for the Symposium, so that we can offer travel scholarships to investigators from under-represented countries and ethnic minorities. NIH support will facilitate education and research in under- represented countries where the HCV epidemic continues unabated. Ultimately, support of the HCV Symposium will lead to improved global control of hepatitis C. PUBLIC HEALTH RELEVANCE: This application seeks to obtain funding to support the 18th International Symposium on Hepatitis C Virus and Related Viruses, to be held in Seattle, WA, USA, from September 8-12, 2011. The HCV Symposium is a world- class meeting focused on the virology, immunology, disease, and treatment of hepatitis C. NIH funds will be used to support the travel to and attendance at HCV2011 of scientists from under-represented countries.

描述（由申请人提供）：全世界有超过1.5亿人感染丙型肝炎病毒（HCV），是导致肝脏疾病的主要原因(1)。在1989年发现丙型肝炎病毒后，于1992年成立了丙型肝炎病毒及相关病毒国际研讨会（以下简称“丙型肝炎病毒研讨会”），其目标是提高对该病毒和疾病的科学认识，并开发控制其传播的新方法。HCV研讨会是对慢性丙型肝炎分子病毒学、发病机制、预防和治疗感兴趣的科学家和临床医生的主要国际会议。2011年9月，来自世界各地的800多名研究人员将聚集在华盛顿州西雅图参加第18届HCV研讨会。研讨会的一个长期目标是通过扩大国际上对研讨会的认识来确保会议的未来，并吸引历史上没有参加过研讨会的国家的科学家。作为这些努力的一部分，西雅图组委会正在获得美国、欧洲、印度、拉丁美洲、亚洲和非洲肝病研究协会的认可。因此，本R13申请寻求NIH对研讨会的支持，以便我们可以为来自代表性不足的国家和少数民族的研究人员提供旅行奖学金。美国国立卫生研究院的支持将促进在HCV流行持续不减的代表性不足的国家的教育和研究。最终，对丙型肝炎研讨会的支持将导致全球丙型肝炎控制的改善。